Abstract:Objective: To investigate the endoscopic combined serological diagnosis strategy for G1 and G2 gastric neuroendocrine neoplasms (G-NENs), and to evaluate the safety, short-term, and long-term efficacy of two endoscopic treatment procedures: endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). Methods: This study retrospectively analyzed the clinical data of 100 consecutive patients with G-NENs who were hospitalized at the Cancer Hospital of the Chinese Academy of Medical Sciences from January 2011 to October 2023. These patients underwent endoscopic treatment, and propensity score matching (PSM) was used to compare clinicopathological characteristics, as well as short-term and long-term efficacy of lesions in the EMR group and ESD group before and after treatment. Results: Among the 100 patients with G-NENs, the median age was 54 years old. Before surgery, 29 cases underwent endoscopic combined serological examination, and 24 of them (82.2%) had abnormally elevated plasma chromogranin A. The combined diagnostic strategy for autoimmune atrophic gastritis (AIG) achieved a diagnostic accuracy of 100%(22/22). A total of 235 G-NEN lesions were included, with 84 in the ESD group and 151 in the EMR group. The median size of the lesions in the ESD group (5.0 mm) was significantly larger than that in the EMR group (2.0 mm, P＜0.001). Additionally, the ESD group had significantly more lesions with pathological grade G2[23.8%(20/84) vs. 1.3%(2/151), P＜0.001], infiltration depth reaching the submucosal layer [78.6%(66/84) vs. 51.0%(77/151), P＜0.001], and more T2 stage compared to the EMR group[15.5%(13/84) vs. 0.7%(1/151), P＜0.001]. After PSM, 49 pairs of lesions were successfully matched between the two groups. Following PSM, there were no significant differences in the en bloc resection rate [100.0%(49/49) vs. 100.0%(49/49)], complete resection rate [93.9%(46/49) vs. 100.0%(49/49)], and complication rate [0(0/49) vs. 4.1%(2/49)] between the two groups. During the follow-up period, no recurrence or distant metastasis was observed in any of the lesions in both groups. Conclusions: The combination of endoscopy and serology diagnostic strategy has the potential to enhance the accuracy of diagnosing G1 and G2 stage G-NENs and their background mucosa. Endoscopic resection surgery (EMR, ESD) is a proven and safe treatment approach for G1 and G2 stage G-NENs.

Values of Seven Tumor Markers in Identification and Diagnosis of Esophageal Carcinoma Accompanied by Neuroendocrine Differentiation

Clinico-pathological characteristics and diagnostic biomarkers in patients with esophageal carcinoma accompanied by neuroendocrine cell differentiation

Combining Serum Calcitonin, Carcinoembryonic Antigen, and Neuron-Specific Enolase to Predict Lateral Lymph Node Metastasis in Medullary Thyroid Carcinoma

Epidemiological investigation of neuroendocrine differentiation in carcinomas: Focus on pancreatic and cholangiocarcinoma cohorts.

Analysis of immunohistochemistry staining, neuronspecific enolase level and somatostatin receptor scintigraphy of 77 cases with digestive neuroendocrine neoplasm

Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms

Clinicopathological Characteristics and Prognosis of Gastrointestinal Cancer with Neuroendocrine Differentiation.

Combined test of serum CgA and NSE improved the power of prognosis prediciton of NF-pNETs.

[Therapeutic Efficacy Analysis of Endoscopic Combined with Serological Diagnosis Strategy and Endoscopic in G1 and G2 Gastric Neuroendocrine Neoplasms].

[Association of Neuroendocrine Differentiation with Progression and Prognosis of Gastric Adenocarcinoma].

Pathologic exploration of neuroendocrine differentiation in carcinomas.

Prognostic Role Of Neuroendocrine Cell Differentiation In Human Gastric Carcinoma

Diagnostic Accuracy of Endoscopic Ultrasonography for Rectal Neuroendocrine Neoplasms

Clinical value of neuroendocrine markers for neoadjuvant chemotherapy response in patients with non-small-cell lung cancer(NSCLC)

Clinicopathological Characteristics and Prognostic Factors of Patients with Gastric Cancer Accompanying Neuroendocrine Differentiation (NEDGC)

Analysis of Clinicopathological Features and Prognosis of Gastric Cancer with Neuroendocrine Cell Differentiation

Elevated Serum Synuclein-Gamma in Patients with Gastrointestinal and Esophageal Carcinomas

[On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer]

[Diagnostic Value of Serum Tumor Markers in Differentiating Malignant from Benign Solitary Pulmonary Nodules].

Clinical Value of Combined Detection of Tumor Markers for Nasopharyngeal Carcinoma and Squamous Cell Carcinoma in Head and Neck

Clinicopathologic Analyses of Primary Small Cell Neuroendocrine Carcinoma of the Esophagus